BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 11777665)

  • 1. Assessment of BMS284756 MIC and 5-microg disk diffusion quality control studies tested against seven American type culture collection strains.
    Biedenbach DJ; Jones RN;
    Diagn Microbiol Infect Dis; 2001 Dec; 41(4):225-8. PubMed ID: 11777665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Re-evaluation of quality control guidelines for gatifloxacin and garenoxacin (BMS284756) when susceptibility testing Haemophilus influenzae and Streptococcus pneumoniae.
    Anderegg TR; Biedenbach DJ; Jones RN;
    Diagn Microbiol Infect Dis; 2003 Jun; 46(2):147-50. PubMed ID: 12812719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative antimicrobial spectrum and activity of BMS284756 (T-3811; a desfluoroquinolone) tested against an international collection of staphylococci and enterococci, including in vitro test development and intermethod comparisons.
    Pfaller MA; Beach ML; Gordon KA; Jones RN
    J Chemother; 2002 Feb; 14(1):13-8. PubMed ID: 11892893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of Disk Diffusion and MIC Quality Control Ranges for Nafithromycin (WCK 4873), a New Lactone-Ketolide.
    Hackel MA; Karlowsky JA; Dressel D; Sahm DF
    J Clin Microbiol; 2017 Oct; 55(10):3021-3027. PubMed ID: 28747372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity of BMS284756 against 2,681 recent clinical isolates of Haemophilus influenzae and Moraxella catarrhalis: Report from The SENTRY Antimicrobial Surveillance Program (2000) in Europe, Canada and the United States.
    Biedenbach DJ; Jones RN; Pfaller MA;
    Diagn Microbiol Infect Dis; 2001 Apr; 39(4):245-50. PubMed ID: 11404068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of disk diffusion and MIC quality control parameters for AZD2563, a novel long-acting oxazolidinone.
    Anderegg TR; Jones RN;
    Diagn Microbiol Infect Dis; 2003 Jan; 45(1):73-6. PubMed ID: 12573554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative antimicrobial spectrum and activity of the desfluoroquinolone BMS284756 (T-3811) tested against non-fermentative Gram-negative bacilli.
    Howard W; Biedenbach DJ; Jones RN
    Clin Microbiol Infect; 2002 Jun; 8(6):340-4. PubMed ID: 12084101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative antimicrobial spectrum and activity of BMS284756 (T-3811, a desfluoroquinolone) tested against 656 Enterobacteriaceae, including preliminary in vitro susceptibility test comparisons and development.
    Fix AM; Pfaller MA; Biedenbach DJ; Beach ML; Jones RN
    Int J Antimicrob Agents; 2001 Aug; 18(2):141-5. PubMed ID: 11516937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Geographic variations in garenoxacin (BMS284756) activity tested against pathogens associated with skin and soft tissue infections: report from the SENTRY Antimicrobial Surveillance Program (2000).
    Kirby JT; Mutnick AH; Jones RN; Biedenbach DJ; Pfaller MA
    Diagn Microbiol Infect Dis; 2002 Aug; 43(4):303-9. PubMed ID: 12151191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of cefditoren MIC quality control ranges by a multi-laboratory study (2001).
    Jones RN; Biedenbach DJ;
    Diagn Microbiol Infect Dis; 2001; 40(1-2):71-3. PubMed ID: 11448567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of disk diffusion and MIC quality control ranges for GSK1322322, a novel peptide deformylase inhibitor.
    Ross JE; Scangarella-Oman NE; Miller LA; Sader HS; Jones RN
    J Clin Microbiol; 2011 Nov; 49(11):3928-30. PubMed ID: 21918031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activity of BMS284756 (T-3811) tested against anaerobic bacteria, Campylobacter jejuni, Helicobacter pylori and Legionella spp.
    Rhomberg PR; Biedenbach DJ; Jones RN
    Diagn Microbiol Infect Dis; 2001; 40(1-2):45-9. PubMed ID: 11448563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activity of gatifloxacin against Haemophilus influenzae and Moraxella catarrhalis, including susceptibility test development, E-test comparisons, and quality control guidelines for H. influenzae.
    Jones RN; Biedenbach DJ; Erwin ME; Beach ML; Pfaller MA
    J Clin Microbiol; 1999 Jun; 37(6):1999-2002. PubMed ID: 10325362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality control guidelines for disk diffusion and broth microdilution antimicrobial susceptibility tests with seven drugs for veterinary applications.
    Odland BA; Erwin ME; Jones RN
    J Clin Microbiol; 2000 Jan; 38(1):453-5. PubMed ID: 10618141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disk diffusion susceptibility testing and broth microdilution quality control guidelines for BMY-28100, a new orally administered cephalosporin.
    Jones RN; Barry AL
    J Clin Microbiol; 1987 Nov; 25(11):2211-3. PubMed ID: 3121667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BMS284756 (formerly T-3811, a des-fluoroquinolone) potency and spectrum tested against over 10,000 bacterial bloodstream infection isolates from the SENTRY antimicrobial surveillance programme (2000).
    Gordon KA; Pfaller MA; Jones RN;
    J Antimicrob Chemother; 2002 May; 49(5):851-5. PubMed ID: 12003983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ofloxacin susceptibility testing quality control parameters for microdilution and disk diffusion, and confirmation of disk diffusion interpretive criteria.
    Fuchs PC; Jones RN; Barry AL; Gavan TL
    J Clin Microbiol; 1989 Jan; 27(1):49-52. PubMed ID: 2492304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative in vitro antimicrobial activity of tigecycline, a new glycylcycline compound, in freshly prepared medium and quality control.
    Brown SD; Traczewski MM
    J Clin Microbiol; 2007 Jul; 45(7):2173-9. PubMed ID: 17494717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activities of BMS 284756 (T-3811) against Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae isolates from SENTRY antimicrobial surveillance program medical centers in Latin America (1999).
    Gales A; Sader H; Jones RN;
    Antimicrob Agents Chemother; 2001 May; 45(5):1463-6. PubMed ID: 11302811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disk diffusion and MIC quality control ranges for BC-3205 and BC-3781, two novel pleuromutilin antibiotics.
    Ross JE; Sader HS; Ivezic-Schoenfeld Z; Paukner S; Jones RN
    J Clin Microbiol; 2012 Oct; 50(10):3361-4. PubMed ID: 22814462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.